title: Hospital recruitment for the Smallpox Pre-Event Vaccination Program: experiences from Florida, Nebraska, New Jersey, and Tennessee, December 2002-June 2003.
abstract: The Smallpox Pre-Event Vaccination Program (SPVP) for public health and hospital-based health care workers began on January 24, 2003. This report summarizes efforts made by health officials in Florida, Nebraska, New Jersey, and Tennessee to facilitate the voluntary participation of acute care hospitals in the SPVP. Seven common characteristics contributed to the success of programs in these four states: (1) early planning, building on existing competencies, and state government support, (2) carrying the program forward on a planned timeline with experienced vaccination staff, (3) use of multifaceted training activities, (4) use of mock scenarios and field exercises to avoid early problems, (5) establishment and fostering of good relationships and lines of communication with stakeholders and the mass media, (6) addressing liability and workers' compensation concerns prior to initiation of the SPVP, and (7) attention to vaccination clinic logistics.
authors.affiliation: Health Services Research and Evaluation Branch, Immunization Services Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333. pching@cdc.gov
authors.forename: Pamela
authors.initials: P
authors.lastname: Ching
authors.forename: William P
authors.initials: WP
authors.lastname: Tynan
authors.forename: Dick
authors.initials: D
authors.lastname: Raymond
authors.forename: Eddy
authors.initials: E
authors.lastname: Bresnitz
authors.forename: Allen S
authors.initials: AS
authors.lastname: Craig
mesh_terms: D023482:Bioterrorism; D005431:Florida; D006282:Health Personnel; D006761:Hospitals; D017589:Immunization Programs / Q000458:organization & administration*; D009329:Nebraska; D009515:New Jersey; D016730:Program Development; D015397:Program Evaluation; D015980:Public Health Practice / Q000592:standards*; D012899:Smallpox / Q000517:prevention & control* / Q000635:transmission; D012900:Smallpox Vaccine / Q000008:administration & dosage*; D013714:Tennessee; D014481:United States
chemical_list: D012900:Smallpox Vaccine